Disease Name |
ICD 11 |
Studied Tissue |
p-value |
Fold-Change |
Z-score |
Acute myelocytic leukaemia
|
2B33.1 |
Bone marrow |
1.07E-24
|
1.76E-01
|
1.40E+00 |
Alzheimer's disease
|
8A20 |
Entorhinal cortex |
1.92E-01
|
-1.05E-01
|
-2.46E-01 |
Asthma
|
CA23 |
Nasal and bronchial airway |
8.36E-02
|
-7.34E-02
|
-1.01E-01 |
Behcet's disease
|
4A62 |
Peripheral blood |
5.60E-01
|
-1.20E-01
|
-5.25E-01 |
Bipolar disorder
|
6A60-6A6Z |
Prefrontal cortex |
9.40E-01
|
4.16E-04
|
1.57E-03 |
Bladder cancer
|
2C94 |
Bladder tissue |
6.23E-01
|
-5.75E-02
|
-3.97E-01 |
Breast cancer
|
2C60-2C6Z |
Breast tissue |
1.67E-05
|
-2.84E-01
|
-6.38E-01 |
Colon cancer
|
2B90 |
Colon tissue |
1.15E-08
|
9.51E-02
|
4.55E-01 |
Diffuse large B-cell lymphoma
|
2A81 |
Tonsil tissue |
7.10E-01
|
4.49E-02
|
2.70E-01 |
Familial hypercholesterolemia
|
5C80.00 |
Peripheral blood |
6.63E-02
|
9.35E-02
|
8.61E-01 |
Gastric cancer
|
2B72 |
Gastric tissue |
3.26E-01
|
1.17E-01
|
4.56E-01 |
Glioblastopma
|
2A00.00 |
Nervous tissue |
6.87E-17
|
-1.42E-01
|
-3.24E-01 |
Head and neck cancer
|
2D42 |
Head and neck tissue |
1.27E-01
|
6.26E-02
|
1.52E-01 |
HIV-associated neurocognitive impairment
|
8A2Y-8A2Z |
White matter tissue |
6.37E-01
|
-2.12E-01
|
-6.01E-01 |
Idiopathic pulmonary fibrosis
|
CB03.4 |
Lung tissue |
3.54E-01
|
-6.01E-03
|
-7.63E-03 |
Interstitial cystitis
|
GC00.3 |
Bladder tissue |
2.94E-02
|
2.97E-01
|
1.40E+00 |
Ischemic stroke
|
8B11 |
Peripheral blood |
9.46E-01
|
-5.20E-03
|
-3.03E-02 |
Liver cancer
|
2C12.0 |
Liver tissue |
1.78E-13
|
-6.78E-01
|
-1.37E+00 |
Liver failure
|
DB99.7-DB99.8 |
Liver tissue |
1.57E-07
|
-1.90E+00
|
-4.66E+00 |
Lung cancer
|
2C25 |
Lung tissue |
1.40E-30
|
3.70E-01
|
9.43E-01 |
Lupus erythematosus
|
4A40 |
Whole blood |
1.54E-03
|
2.21E-02
|
1.27E-01 |
Major depressive disorder
|
6A70-6A7Z |
Hippocampus |
5.88E-01
|
1.68E-02
|
7.00E-02 |
Multiple myeloma
|
2A83.1 |
Bone marrow |
2.81E-03
|
-5.05E-01
|
-1.74E+00 |
Multiple myeloma
|
2A83.1 |
Peripheral blood |
1.23E-01
|
1.08E-01
|
9.67E-01 |
Multiple sclerosis
|
8A40 |
Plasmacytoid dendritic cells |
6.18E-01
|
-1.41E-02
|
-7.46E-02 |
Myelodysplastic syndrome
|
2A36-2A3Z |
Bone marrow |
1.72E-08
|
3.01E-01
|
1.11E+00 |
Myocardial infarction
|
BA41-BA50 |
Peripheral blood |
3.72E-01
|
3.16E-04
|
3.73E-04 |
Neuroectodermal tumour
|
2A00.11 |
Brain stem tissue |
8.61E-01
|
-5.50E-02
|
-3.13E-01 |
Non-alcoholic fatty liver disease
|
DB92 |
Liver tissue |
4.44E-03
|
-3.98E-01
|
-1.27E+00 |
Obesity related type 2 diabetes
|
5A11 |
Omental adipose tissue |
7.37E-01
|
-5.05E-02
|
-2.88E-01 |
Olive pollen allergy
|
CA08.00 |
Peripheral blood |
1.91E-01
|
-8.22E-02
|
-6.30E-01 |
Oral cancer
|
2B6E |
Oral tissue |
1.31E-02
|
2.02E-01
|
4.10E-01 |
Ovarian cancer
|
2C73 |
Ovarian tissue |
5.52E-01
|
-1.33E-01
|
-3.82E-01 |
Pancreatic cancer
|
2C10 |
Pancreas |
3.79E-03
|
-5.72E-01
|
-1.04E+00 |
Parkinson's disease
|
8A00.0 |
Substantia nigra tissue |
3.07E-01
|
-8.64E-02
|
-3.70E-01 |
Pituitary cancer
|
2D12 |
Pituitary tissue |
7.86E-01
|
1.08E-02
|
4.02E-02 |
Polycystic ovary syndrome
|
5A80.1 |
Vastus lateralis muscle |
8.58E-01
|
-7.09E-02
|
-5.97E-01 |
Pompe disease
|
5C51.3 |
Biceps muscle |
8.44E-01
|
1.15E-02
|
5.27E-02 |
Prostate cancer
|
2C82 |
Prostate |
3.45E-04
|
1.08E+00
|
1.26E+00 |
Psoriasis
|
EA90 |
Skin |
7.17E-34
|
1.22E+00
|
3.04E+00 |
Rectal cancer
|
2B92 |
Rectal colon tissue |
1.38E-01
|
1.75E-01
|
8.79E-01 |
Renal cancer
|
2C90-2C91 |
Kidney |
1.13E-01
|
2.52E-02
|
8.23E-02 |
Retinoblastoma
|
2D02.2 |
Uvea |
3.05E-01
|
7.87E-02
|
7.21E-01 |
Schizophrenia
|
6A20 |
Prefrontal cortex |
6.56E-02
|
9.58E-04
|
3.56E-03 |
Schizophrenia
|
6A20 |
Superior temporal cortex |
2.40E-01
|
2.84E-02
|
1.49E-01 |
Scleroderma
|
4A42.Z |
Whole blood |
1.34E-01
|
4.93E-02
|
5.31E-01 |
Seizure
|
8A60-8A6Z |
Whole blood |
9.12E-01
|
1.17E-02
|
1.04E-01 |
Sepsis with septic shock
|
1G41 |
Whole blood |
1.68E-05
|
8.65E-02
|
3.84E-01 |
Sickle cell disease
|
3A51.0-3A51.3 |
Peripheral blood |
6.86E-01
|
-1.56E-02
|
-8.66E-02 |
Simpson golabi behmel syndrome
|
LD2C |
Adipose tissue |
3.39E-01
|
-5.11E-02
|
-1.44E+00 |
Sjogren's syndrome
|
4A43.2 |
Salivary gland tissue |
9.09E-02
|
2.56E-01
|
2.00E+00 |
Skin cancer
|
2C30-2C3Z |
Skin |
4.06E-40
|
8.02E-01
|
1.89E+00 |
Thrombocythemia
|
3B63 |
Whole blood |
1.53E-02
|
7.54E-02
|
5.79E-01 |
Thrombocytopenia
|
3B64 |
Whole blood |
9.62E-01
|
5.94E-02
|
3.66E-01 |
Thyroid cancer
|
2D10 |
Thyroid |
1.22E-41
|
-1.04E+00
|
-2.45E+00 |
Tibial muscular dystrophy
|
8C75 |
Muscle tissue |
7.78E-02
|
6.64E-02
|
8.61E-01 |
Tuberous sclerosis complex
|
LD2D.2 |
Perituberal tissue |
3.19E-02
|
1.81E-01
|
6.94E+00 |
Type 2 diabetes
|
5A11 |
Liver tissue |
6.00E-01
|
5.07E-02
|
1.74E-01 |
Ureter cancer
|
2C92 |
Urothelium |
5.84E-01
|
-2.64E-03
|
-2.35E-02 |
Uterine cancer
|
2C78 |
Endometrium tissue |
3.41E-02
|
6.50E-02
|
1.09E-01 |
Vitiligo
|
ED63.0 |
Skin |
1.50E-01
|
-8.91E-02
|
-4.49E-01 |
------------------------------------------------------------------------------------ |
|
|
|
|
|